Cliquez ici pour connaître notre offre FCPI et Mandat de gestion

The fast pace of innovation in IT offers compelling investment opportunities

Truffle Capital is a pioneer investor in the exciting field of Energy

Biotechnology has radically transformed medicine over the past 25 years


  • “ Truffle Capital has been an industrial, strategic and financial partner to Vexim since the creation of the company in 2006 and has enabled Vexim to acquire an international role within the treatment of spine fractures. The Truffle Capital partners are passionate entrepreneurs, keen on innovation and understand a company’s needs and its people. They have taken measured risks, helped Vexim in fulfilling its aims and accompanied us in our progress, for which we are very grateful. ”Vexim
    Vincent Gardes / CEO

Truffle Capital is an independent European venture capital firm

Established in 2001, Truffle Capital, with €700 million under management and advisory via institutional and retail private equity funds as of December 30th 2014, Truffle Capital is an important and independent European private equity firm, specialised in investments in the Information Technology and Life Sciences sectors, in spin-offs and companies developping breakthrough technologies and products. Every year Truffle Capital launch a new FCPI fund (mutual fund investing in innovative companies). The firm is led by a team of three General Partners with decades of successful investment and entrepreneurial experience in both Europe and in the USA.

Backed by an investment team of international experts and an experienced support team, a total of 17 professionals, Truffle Capital aims to achieve superior financial returns by leveraging its industry knowledge, extensive network, and operational experience to identify business opportunities that match latent market needs.

Truffle CapitalonGoogle+


07-2015

DEINOVE

8th July – Deinove reaches the third milestone of the Deinol program and receives €1.2 M from Bpi France

Pdf


+ read more
07-2015

ABIVAX

3rd July 2015 – ABIVAX commends Cuba on being the first country in the world to eliminate mother-to-child transmission of HIV

Pdf


+ read more
07-2015

NEOVACS

Le 2 juillet 2015 – Augmentation de capital de 7.5 M€

Pdf


+ read more
07-2015

DENY-ALL

1st July 2015 – DenyAll Bug Bounty a success at Nuit du Hack 2015

Pdf


+ read more